Adverse effects of immunoglobulin therapy

Y Guo, X Tian, X Wang, Z Xiao - Frontiers in immunology, 2018 - frontiersin.org
Immunoglobulin has been widely used in a variety of diseases, including primary and
secondary immunodeficiency diseases, neuromuscular diseases, and Kawasaki disease …

The natural history of ataxia-telangiectasia (AT): a systematic review

E Petley, A Yule, S Alexander, S Ojha… - PLoS One, 2022 - journals.plos.org
Background Ataxia-telangiectasia is an autosomal recessive, multi-system, and life-
shortening disease caused by mutations in the ataxia-telangiectasia mutated gene …

Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence

P Cherin, I Marie, M Michallet, E Pelus, J Dantal… - Autoimmunity …, 2016 - Elsevier
Immunoglobulin (IG) therapy is actually used for a broad range of diseases including
primary and secondary immunodeficiency disorders, and autoimmune diseases. This …

Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry

A Aghamohammadi, P Mohammadinejad… - Journal of clinical …, 2014 - Springer
Background Primary immunodeficiency disorders (PID) are a group of heterogeneous
disorders mainly characterized by severe and recurrent infections and increased …

Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: a guide for the dermatologist

A Martinez-Lopez, C Cuenca-Barrales… - Journal of the American …, 2020 - Elsevier
The new coronavirus, severe acute respiratory syndrome coronavirus 2, is associated with a
wide variety of cutaneous manifestations. Although new skin manifestations caused by …

A review on guidelines for management and treatment of common variable immunodeficiency

H Abolhassani, BT Sagvand, T Shokuhfar… - Expert review of …, 2013 - Taylor & Francis
Common variable immunodeficiency (CVID) is the most common symptomatic primary
immunodeficiency in adults. As symptoms of CVID are usually heterogeneous and …

Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behçet's syndrome

A Bettiol, M Becatti, E Silvestri… - Clinical & …, 2021 - academic.oup.com
Behçet's syndrome (BS) is a systemic vasculitis with several clinical manifestations.
Neutrophil hyperactivation mediates vascular BS pathogenesis, via both a massive reactive …

Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions

DC Bichuetti-Silva, FP Furlan, FA Nobre… - International …, 2014 - Elsevier
Intravenous immunoglobulin (IVIG) is increasingly recommended for many diseases apart
from primary immunodeficiency diseases (PID). Although effective and safe, adverse …

Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective study

FRR Palabrica, SL Kwong, FR Padua - Asia Pacific Allergy, 2013 - journals.lww.com
Adverse events of intravenous immunoglobulin infusions: a te... : Asia Pacific Allergy Adverse
events of intravenous immunoglobulin infusions: a ten-year retrospective study : Asia Pacific …

Indications and safety of intravenous and subcutaneous immunoglobulin therapy

N Rezaei, H Abolhassani… - Expert review of …, 2011 - Taylor & Francis
Immunoglobulin (Ig) therapy is an important method of treatment for a number of
immunological, hematological, neurological and dermatological disorders. Over the years …